We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.7B
AUM Growth
+$354M
Cap. Flow
+$180M
Cap. Flow %
4.86%
Top 10 Hldgs %
45.26%
Holding
381
New
32
Increased
193
Reduced
114
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 13.99%
2 Healthcare 6.23%
3 Financials 4.09%
4 Communication Services 2.89%
5 Industrials 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHD icon
201
Schwab US Dividend Equity ETF
SCHD
$103B
$784K 0.02%
27,825
+18,093
+186% +$493K
AMP icon
202
Ameriprise Financial
AMP
$48.3B
$780K 0.02%
1,661
-28
-2% -$12.1K
HIPS icon
203
GraniteShares HIPS US High Income ETF
HIPS
$109M
$778K 0.02%
59,946
+8,110
+16% +$105K
VGT icon
204
Vanguard Information Technology ETF
VGT
$139B
$774K 0.02%
10,552
+8
+0.1% +$569
SDY icon
205
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$768K 0.02%
5,404
+65
+1% +$8.79K
VBR icon
206
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$744K 0.02%
3,704
+11
+0.3% +$2.12K
T icon
207
AT&T
T
$159B
$738K 0.02%
33,530
+2,245
+7% +$44.7K
APD icon
208
Air Products & Chemicals
APD
$65.7B
$735K 0.02%
2,469
+209
+9% +$57.2K
AFL icon
209
Aflac
AFL
$64.9B
$734K 0.02%
6,564
+53
+0.8% +$5.39K
ECL icon
210
Ecolab
ECL
$78.1B
$731K 0.02%
2,864
-45
-2% -$11K
BSX icon
211
Boston Scientific
BSX
$69.5B
$670K 0.02%
7,992
+80
+1% +$6.31K
TRIN icon
212
Trinity Capital Inc.
TRIN
$1.58B
$668K 0.02%
49,221
+29,173
+146% +$412K
IGSB icon
213
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$644K 0.02%
12,237
-447
-4% -$23.3K
OEF icon
214
iShares S&P 100 ETF
OEF
$20.1B
$639K 0.02%
2,308
-61
-3% -$16.3K
PM icon
215
Philip Morris
PM
$297B
$634K 0.02%
5,221
+194
+4% +$22.5K
AVLC icon
216
Avantis US Large Cap Equity ETF
AVLC
$1.37B
$632K 0.02%
+9,574
New +$609K
D icon
217
Dominion Energy
D
$60.8B
$630K 0.02%
10,910
+67
+0.6% +$3.66K
SHEL icon
218
Shell
SHEL
$254B
$598K 0.02%
9,062
+691
+8% +$48.9K
SUB icon
219
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$596K 0.02%
5,610
+28
+0.5% +$2.95K
OTIS icon
220
Otis Worldwide
OTIS
$27.4B
$585K 0.02%
5,633
+413
+8% +$39.3K
SCHM icon
221
Schwab US Mid-Cap ETF
SCHM
$14.5B
$583K 0.02%
21,063
+78
+0.4% +$2.07K
TRV icon
222
Travelers Companies
TRV
$78.1B
$573K 0.02%
2,446
-9
-0.4% -$1.98K
BCRX icon
223
BioCryst Pharmaceuticals
BCRX
$2.28B
$572K 0.02%
75,275
ROK icon
224
Rockwell Automation
ROK
$53.4B
$568K 0.02%
2,114
+15
+0.7% +$3.98K
ED icon
225
Consolidated Edison
ED
$40.1B
$565K 0.02%
5,427
+169
+3% +$16.7K

Similar funds

Grimes & Company's Q3 2024 Portfolio in Review

As of Q3 2024, Grimes & Company held 381 positions worth $3.7B, up 11% from $3.34B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company deployed $180M of net new capital in Q3 2024, opening 32 new positions and adding to 193 existing holdings. Its largest new stake was State Street Industrial Select Sector SPDR ETF: 231,081 shares worth $31.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was RTX Corp, an estimated $17.9M trimmed.

  • Grimes & Company's largest Q3 2024 buy was State Street Industrial Select Sector SPDR ETF: 231,081 shares worth $31.3M.
  • Grimes & Company added most to Vanguard Morningstar Small-Cap ETF in Q3 2024, an estimated $120M increase.
  • Grimes & Company's biggest Q3 2024 reduction was RTX Corp, cutting an estimated $17.9M.
  • Grimes & Company fully exited iShares 0-1 Year Treasury Bond ETF in Q3 2024, selling an estimated $454K.
  • Grimes & Company's ten largest holdings make up 45% of its $3.7B portfolio in Q3 2024.
  • Grimes & Company opened 32 new positions and closed 15 in Q3 2024.
  • Grimes & Company's portfolio value rose 11% quarter-over-quarter to $3.7B.

Based on Grimes & Company's 13F filing for Q3 2024, filed 22 Oct 2024.